Autor: |
Dominik Machaj, Alicja Płaczek, Katarzyna Cyboran, Agnieszka Siedlak, Filip Białas |
Jazyk: |
English<br />Spanish; Castilian<br />Polish<br />Russian<br />Ukrainian |
Rok vydání: |
2022 |
Předmět: |
|
Zdroj: |
Journal of Education, Health and Sport, Vol 12, Iss 8 (2022) |
Druh dokumentu: |
article |
ISSN: |
2391-8306 |
DOI: |
10.12775/JEHS.2022.12.08.035 |
Popis: |
Rheumatoid arthritis is a systemic autoimmune disease of connective tissue of unknown etiology. Specific for it is the involvement of symmetrically small and medium-sized joints, leading to degradation of their structure, stiffening and muscle contractures. It is also characterized by extra-articular and generalized symptoms, such as fatigue, low-grade fever and sweating. It can occur with or without elevated RF and / or ACPA antibodies, causes disability and contributes to premature death. Drugs for this disease can be categorized into disease-modifying drugs as well as glucocorticosteroids and non-steroidal anti-inflammatory drugs. The first-line drug is methotrexate. In case of ineffectiveness of the treatment, biological treatment can be started. |
Databáze: |
Directory of Open Access Journals |
Externí odkaz: |
|